Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Mikesch · SciRah

Researcher profile · Semantic Scholar

J. Mikesch

Share profile

J. Mikesch — researcher profile on SciRah

h-index: 22
Works: 128
Citations: 2,187

Most-cited papers

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3
M. Levis, M. Hamadani, Brent Logan, Richard J. Jones +35 more
2024Journal of Clinical Oncology183 citations Open access
Semantic Scholar
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
C. Röllig, M. Kramer, C. Schliemann, J. Mikesch +38 more
2020Blood109 citations Open access
Semantic Scholar
Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.
L. Angenendt, C. Röllig, P. Montesinos, D. Martínez-Cuadrón +41 more
2019Journal of Clinical Oncology103 citations Open access
Semantic Scholar
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells.
S. Kailayangiri, B. Altvater, S. Lesch, S. Balbach +16 more
2019Molecular Therapy103 citations Open access
Semantic Scholar
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy
M. Wass, S. Göllner, B. Besenbeck, R. Schlenk +20 more
2020Leukemia83 citations Open access
Semantic Scholar
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
C. Larrue, N. Guiraud, P. Mouchel, Marine Dubois +21 more
2020Nature Communications61 citations Open access
Semantic Scholar
Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells.
M. Yusenko, A. Trentmann, M. Andersson, L. A. Ghani +6 more
2020Cancer Letters59 citations
Semantic Scholar
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
M. Stelljes, J. Middeke, G. Bug, E. Wagner-Drouet +32 more
2024The Lancet Haematology45 citations Open access
Semantic Scholar
The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia
L. Angenendt, E. Bormann, C. Pabst, V. Alla +30 more
2019Leukemia43 citations Open access
Semantic Scholar
SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma
I. Isfort, M. Cyra, S. Elges, S. Kailayangiri +15 more
2019Clinical Cancer Research40 citations Open access
Semantic Scholar
In Patients with Relapsed/Refractory AML Sequential Conditioning and Immediate Allogeneic Stem Cell Transplantation (allo-HCT) Results in Similar Overall and Leukemia-Free Survival Compared to Intensive Remission Induction Chemotherapy Followed By Allo-HCT: Results from the Randomized Phase III ASAP
M. Stelljes, J. Middeke, G. Bug, E. Wagner +26 more
2022Blood34 citations Open access
Semantic Scholar
High‐dose melphalan‐based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia
N. Steckel, C. Groth, J. Mikesch, R. Trenschel +13 more
2018British Journal of Haematology28 citations Open access
Semantic Scholar
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia
L. Ruhnke, Marius Bill, Sven Zukunft, J. Eckardt +44 more
2024Blood Advances27 citations Open access
Semantic Scholar
Pulmonary Toxicity after Total Body Irradiation—An Underrated Complication? Estimation of Risk via Normal Tissue Complication Probability Calculations and Correlation with Clinical Data
M. Oertel, C. Kittel, Jonas Martel, J. Mikesch +3 more
2021Cancers24 citations Open access
Semantic Scholar
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial
T. Schroeder, M. Stelljes, M. Christopeit, Eva Esseling +13 more
2023Haematologica22 citations Open access
Semantic Scholar
Overexpression and Tyr421-phosphorylation of cortactin is induced by three-dimensional spheroid culturing and contributes to migration and invasion of pancreatic ductal adenocarcinoma (PDAC) cells
Katharina Stock, Rebekka Borrink, J. Mikesch, A. Hansmeier +6 more
2019Cancer Cell International22 citations Open access
Semantic Scholar
Low‐density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia
Matthias Floeth, S. Elges, J. Gerss, C. Schwöppe +9 more
2020British Journal of Haematology21 citations Open access
Semantic Scholar
C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia
M. Yusenko, A. Trentmann, D. A. Casolari, Luca Abdel Ghani +12 more
2021Oncogene20 citations Open access
Semantic Scholar
Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia.
C. Röllig, M. Kramer, C. Schliemann, J. Mikesch +38 more
2019Blood19 citations Open access
Semantic Scholar
Focal adhesion kinase confers pro‐migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma
K. Steinestel, M. Trautmann, Esther-Pia Jansen, U. Dirksen +10 more
2019bioRxiv19 citations Open access
Semantic Scholar
Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia
C. Röllig, B. Steffen, C. Schliemann, J. Mikesch +40 more
2024Journal of Clinical Oncology16 citations
Semantic Scholar
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens
David Baden, Sven Zukunft, Gema Hernández, Nadine Wolgast +35 more
2024Haematologica15 citations Open access
Semantic Scholar
Dexamethasone‐mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells
H. Ahmed, S. C. Nimmagadda, Y. Al-Matary, Maren Fiori +16 more
2021British Journal of Haematology15 citations Open access
Semantic Scholar
Calcitonin receptor‐like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML
L. Angenendt, M. Wöste, J. Mikesch, M. Arteaga +8 more
2021Blood Advances15 citations Open access
Semantic Scholar
Venetoclax Plus High-Dose Cytarabine and Mitoxantrone (HAM-Ven) As Salvage Treatment for Relapsed/Refractory AML: Updated Results of the Phase-I/II SAL Relax Trial
L. Ruhnke, C. Schliemann, J. Mikesch, M. Stelljes +25 more
2023Blood14 citations Open access
Semantic Scholar
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis.
Patrick Stelmach, Klaus Wethmar, C. Groth, Daniela V. Wenge +7 more
2020Clinical Lymphoma, Myeloma & Leukemia14 citations
Semantic Scholar
Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial
M. Stelljes, J. Middeke, G. Bug, E. Wagner-Drouet +32 more
2025Blood13 citations
Semantic Scholar
Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial
C. Röllig, B. Steffen, C. Schliemann, J. Mikesch +37 more
2022Blood13 citations Open access
Semantic Scholar
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
A. Berdel, L. Ruhnke, L. Angenendt, M. Wermke +20 more
2022Blood Advances12 citations Open access
Semantic Scholar
The Burden of Survivorship on Hematological Patients—Long-Term Analysis of Toxicities after Total Body Irradiation and Allogeneic Stem Cell Transplantation
M. Oertel, Jonas Martel, J. Mikesch, S. Scobioala +5 more
2021Cancers12 citations Open access
Semantic Scholar
AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report
J. Mikesch, W. Hartmann, L. Angenendt, O. Huber +7 more
2018Cellular Oncology12 citations Open access
Semantic Scholar
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis
Julian Ronnacker, Philippe J. Muller, J. Mikesch, Sven Zukunft +50 more
2025Leukemia11 citations Open access
Semantic Scholar
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia
Daniela V. Wenge, Klaus Wethmar, Corinna A. Klar, H. Kolve +15 more
2022Cancers11 citations Open access
Semantic Scholar
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry
M. Hanoun, L. Ruhnke, M. Kramer, Christine Hanoun +29 more
2022Journal of Cancer Research and Clinical Oncology11 citations Open access
Semantic Scholar
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma
Christine Eisfeld, Eva Esseling, R. Wullenkord, Cyrus Khandanpour +10 more
2020Annals of Hematology11 citations Open access
Semantic Scholar
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)
T. Kessler, S. Koschmieder, C. Schliemann, M. Crysandt +14 more
2019Annals of Hematology11 citations
Semantic Scholar
Gemtuzumab Ozogamicin Plus Midostaurin in Combination with Standard Intensive Induction Therapy in Newly Diagnosed AML: Results from a Phase-I Study
C. Röllig, C. Schliemann, J. Mikesch, L. Fransecky +15 more
2021Blood10 citations
Semantic Scholar
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia
Klaus Wethmar, S. Matern, Eva Esseling, L. Angenendt +12 more
2020Bone Marrow Transplantation10 citations
Semantic Scholar
Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia
Eloisa Felipe Fumero, C. Walter, J. Frenz, F. Seifert +16 more
2024Blood9 citations Open access
Semantic Scholar
Gemtuzumab ozogamicin plus midostaurin in combination with standard ‘7 + 3’ induction therapy in newly diagnosed AML: Results from the SAL‐MODULE phase I study
C. Röllig, C. Schliemann, L. Ruhnke, L. Fransecky +16 more
2024British Journal of Haematology9 citations Open access
Semantic Scholar
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
L. Angenendt, Isabel Hilgefort, J. Mikesch, B. Schlüter +4 more
2020Annals of Hematology9 citations Open access
Semantic Scholar
Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancer
J. Mikesch, Daniela Schwammbach, W. Hartmann, L. Schmidt +11 more
2018European Respiratory Journal9 citations Open access
Semantic Scholar
Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario
Carolin Krekeler, L. Reitnauer, Ulrike Bacher, C. Khandanpour +16 more
2022Cancers8 citations Open access
Semantic Scholar
Stromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancer
L. Angenendt, J. Mikesch, D. Görlich, Alina Busch +8 more
2018Cellular Oncology8 citations Open access
Semantic Scholar
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia
Julian Ronnacker, Marc-André Urbahn, C. Reicherts, Lina J. Kolloch +11 more
2024British Journal of Haematology7 citations Open access
Semantic Scholar
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)
A. Pohlmann, Eva Bentgens, C. Schülke, D. Kuron +7 more
2023Annals of Hematology7 citations Open access
Semantic Scholar
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience
Julius C. Enßle, S. Wolf, Sebastian Scheich, Sarah Weber +29 more
2023British Journal of Cancer7 citations Open access
Semantic Scholar
Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation
C. Schliemann, T. Kessler, A. Berdel, T. Hemmerle +9 more
2021British Journal of Haematology7 citations Open access
Semantic Scholar
An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia
L. Angenendt, S. Reuter, D. Kentrup, A. Benk +18 more
2018Leukemia7 citations
Semantic Scholar
Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis
D. Kuron, A. Pohlmann, L. Angenendt, T. Kessler +6 more
2023Annals of Hematology6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Schliemann×40
Invite
C. Schliemann — researcher profile on SciRah
G. Lenz×20
Invite
G. Lenz — researcher profile on SciRah
M. Stelljes×19
Invite
M. Stelljes — researcher profile on SciRah
C. Röllig×18
Invite
C. Röllig — researcher profile on SciRah

×18

Invite

W. Berdel — researcher profile on SciRah

C. Müller-Tidow×17

Invite

C. Müller-Tidow — researcher profile on SciRah

Invite

H. Serve — researcher profile on SciRah

M. Bornhäuser×16

Invite

M. Bornhäuser — researcher profile on SciRah

L. Angenendt×16

Invite

L. Angenendt — researcher profile on SciRah

U. Platzbecker×14

Invite

U. Platzbecker — researcher profile on SciRah

K. Schäfer-Eckart×12

Invite

K. Schäfer-Eckart — researcher profile on SciRah

L. Fransecky×12

Invite

L. Fransecky — researcher profile on SciRah